Allergan’s acute migraine treatment wins U.S. FDA approval
By Manojna Maddipatla (Reuters) – The U.S. Food and Drug Administration said on Monday it...
Read MoreDec 23, 2019
By Manojna Maddipatla (Reuters) – The U.S. Food and Drug Administration said on Monday it...
Read MoreDec 23, 2019
By Lisa Rapaport (Reuters Health) – Interactive educational apps may be able to help young...
Read MoreDec 23, 2019
No temporal association found for short sleep duration, low sleep quality with migraine. MONDAY,...
Read MoreDec 23, 2019
Progression-free survival longer in those receiving tivozanib as third- or fourth-line therapy...
Read MoreDec 23, 2019
Mortality rates significantly higher for territory-dwelling Hispanic and Asian dialysis patients...
Read MoreDec 23, 2019
Children should be referred for intervention at time of identification and not wait for diagnostic...
Read MoreDec 23, 2019
(This Dec.20 story corrects first paragraph to say the approval came four months ahead of...
Read MoreDec 23, 2019
MILAN (Reuters) – A Milan court on Monday acquitted right-to-die activist Marco Cappato of aiding suicide, following a landmark constitutional court ruling which breached Italy’s traditional rejection of helping...
Read MoreDec 23, 2019
By Huizhong Wu BEIJING (Reuters) – An unmarried Chinese woman filed a suit against a...
Read MoreDec 23, 2019
Even with use of the best treatments currently available, treatment for childhood anxiety...
Read MoreDec 23, 2019
MANILA (Reuters) – At least 11 people have been killed and more than 300 treated in hospital...
Read MoreDec 23, 2019
By Trisha Roy (Reuters) – Intra-Cellular Therapies Inc said on Monday its lead drug to treat schizophrenia in adults has received approval from the U.S. Food and Drug Administration, sending its shares soaring 85%. The...
Read MoreDec 23, 2019
By Trisha Roy (Reuters) – Japan-based drugmaker Eisai Co’s U.S. subsidiary announced...
Read MoreDec 23, 2019
(Reuters) – NMC Health has launched an independent review of its books, seeking to reassure investors after U.S. short-selling firm Muddy Waters last week questioned the healthcare group’s finances. Muddy Waters...
Read MoreDec 23, 2019
By Bill Trott (Reuters) – Ram Dass, who in the 1960s joined Timothy Leary in promoting psychedelic drugs as the path to inner enlightenment before undergoing a spiritual rebirth he spelled out in the influential book...
Read MoreDec 23, 2019
However, fate of the program remains uncertain
Read MoreDec 23, 2019
Progression-free survival longer in those receiving tivozanib as third- or fourth-line therapy
Read MoreDec 23, 2019
However, no association seen between hypothyroidism and cardiovascular mortality
Read MoreDec 23, 2019
Also no significant decrease seen in cancer death in studies from 2005 onward
Read MoreDec 23, 2019
Among critically ill patients with vitamin D deficiency, supplementation did not improve 90-day mortality
Read More